Abstract
Oral submucous fibrosis is a chronic disease affecting oral cavity and sometimes the pharynx. Etiology seems to be local irritants such as capsaicin, tobacco, areca nut and spicy foods. The main concern in this is the management of trismus and burning sensation of the oral mucosa. The aim of this study was to compare various medical treatment protocol of OSMF. 210 patients were divided randomly in 3 groups. In Group A, patients were given biweekly intralesional Hyaluronidase/Dexamethasone for 6 weeks. Group B patients were given tablet Pentoxifylline 400 mg TDS.Group C patients were given Eprisone hydrochloride. All three groups were given Lycopene 10,000 mcg for period of 6 weeks. All patients were given topical Triamcelone for local application. The examinations for mouth opening were repeated at weekly intervals for a period of 6 weeks.The most common complaint was burning sensation in 75.98% cases, difficulty in mouth opening in77.45% and difficulty in swallowing food in 61.76% cases. Group A showed improvement in 41.17% cases presenting with burning sensation followed by decreased mouth opening 39.70%. Group B showed improvement in 45.58% burning sensation, 17.64% with decreased mouth opening. Group C showed improvement in 48.52% patients having pain with spicy food, 32.35% with decreased mouth opening and 17.64% with difficulty in swallowing. We conclude that patients which received intralesional dexamethasone and hyaluronidase along with oral Lycopene showed better clinical and symptomatic improvement, and at present appears to be best non-surgical treatment.
Similar content being viewed by others
References
J Schwartz 1952 Atrophia Idiopathica (tropica) mucosae oris. Demonstrated at the Eleventh International Dental Congress, London, 1952 (cited by Sirsat & Khanolkar) Ind J Med Sci 16 189 197
SG Joshi 1953 Submucous fibrosis of the palate and pillars Ind J Otolaryngol Head Neck Surg 4 1 4
Anuradha CD, Devi CS (1993) Serum protein, ascorbic acid & iron & tissue collagen in oral submucous fibrosis –a preliminary study. Indian J Med Res 98:147–51
R Rajendran 1994 Oral submucous fibrosis: etiology, pathogenesis, and future research WHO Bull OMS 72 6 985 996
Hammer JE, Mehta FS, Pindborg JJ, Daftary DK (2016) Altered staining reaction of connective tissues in 53 submucous fibrosis patients. J Dent Res 50(2):388–392. https://doi.org/10.1177/00220345710500024601
LK Sharma AK Gupta RD Mukhija P Nigam 1987 Clinical experience with the use of peripheral vasodilator in oral disorders Int J Oral Maxillo Fac Surg 16 6 695 699
SS Nichlani MV Jagade A Ganeshan 2011 Benefits of using muscle relaxants in the routine treatment protocol of oral submucosal fibrosis: a pilot study Indian J Otolaryngol Head Neck Surg 63 4 317 320
R Mehrotra HP Singh SC Gupta M Singh S Jain 2011 Pentoxifylline therapy in the management of oral submucous fibrosis Asian Pac J Cancer Prev 12 4 971 974
SR Aziz 2009 Lack of reliable evidence for oral submucous fibrosis treatments Evid Based Dent 10 1 8 9
Gowda BBK, Yathish TR, Sinhasan PS, Naik HK, Somayaji P, Anand D (2011) The response of oral submucous fibrosis to lycopene – a carotenoid antioxidant: a clinicopathological study. J Clin Diag Res 5(4):882–888
RM Borle SR Borle 1991 Management of oral; submucous fibrosis: a conservative approach J Oral Maxillofac Surg 49 8 788 791
N Elizabeth S Gurumani GA Bala George Tukalan 2014 A comparative study between management of oral submucous fibrosis J Evolut Med Dental Sci 3 47 11344 48
S Goel J Ahmed MP Singh P Nahar 2010 Oral submucous fibrosis: a clinico-histopthological comparative study in population of Southern Rajasthan J Carcinogenesis Mutagenesis 1 108
JJ Pindborg FS Mehta PC Gupta DK Daftary 1968 Prevalance of oral submucous fibrosis among 50,915 Indian villagers Br J Cancer 22 4 646 654
PA Hayes 1985 Oral submucous fibrosis in a 4-year-old girl Oral Surg Oral Med Oral Pathol 59 5 475 478
PN Sinor PC Gupta PR Murti RB Bhonsle DK Daftary FS Mehta 1990 A case control study of oral submucous fibrosis with special reference to the aetiologic role of areca nut J Oral Pathol Med 19 2 94 98
PV Vanaja Reddy NR Wanjari PR Banda 2011 Oral submucous fibrosis: correlation of clinical grading to various habit factors Int J Dent Clin 3 21 24
RB Bhonsle PR Murti DK Daftary PC Gupta FS Mehta PN Sinor 1987 Regional variations in oral submucous fibrosis in India Commun Dent Oral Epidemiol 15 4 225 229
Gaur SK, Sinha ON, Madan J (2013) A study and evaluation of various modalities of non-surgical treatment in oral submucous fibrosis. Int J Institut Pharm Life Sci 3(5):1–4
A Auluck MP Rosin L Zhang KN Sumanth 2008 Oral submucous fibrosis, a clinically benign but potentially malignant disease: report of 3 cases and review of the literature J Can Dent Assoc 74 8 735 740
JC Paymaster 1956 Cancer of the buccal mucosa. A clinical study in 650 cases in Indian patients Cancer 9 3 431 5
PN Wahi VL Kapur UK Luthra MC Srivastava 1966 Submucous fibrosis of the oral cavity: histomorphological studies Br J Cancer 20 676 687
JJ Pindborg FS Mehta PC Gupta DK Daftary 1968 Prevalance of oral submucous fibrosis among 50,915 Indian villagers Br J Cancer 22 4 646 654
NP Selvam AA Dayanand 2013 Lycopene in the management of oral submucous fibrosis Asian J Pharm Clin Res 6 3 58 61
PK Kakar RK Puri VP Venkatachalam 1985 Oral submucous fibrosis-treatment with hylase J Laryngolotol 99 1 57 59
L James A Shetty D Rishi M Abraham 2015 Management of oral submucous fibrosis with injection of hyaluronidase and dexamethasone in grade III oral submucous fibrosis: a retrospective study J Int Oral Health 7 8 1 4
Gupta J, Srinivasan SV, Jonathan Daniel M (2012) Efficacy of betamethasone, placental extract and hyaluronidase in the treatment of osmf: a comparative study. e-J. Dent 2(1):132–135
D Singh MC Shashikanth N Misra S Agrawal 2014 Lycopene and intralesional betamethasone injections in the management of oral submucous fibrosis J Indian Acad Oral Med Radiol 26 264 268
R Rajendran V Rani S Shaikh 2006 Pentoxifylline therapy : a new adjunct in the treatment of oral submucous fibrosis Indian J Dent Res 17 190 198
BJ Chetan UR Hemant K Shah H Valimaa 2013 Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis Clin Oral Investig 17 5 1375 1382
S Patil MG Sghaireen S Maheshwari SR Kunsi R Sahu 2015 Comparative study of the efficacy of Lycopene and Aloe Vera in the treatment of oral submucous fibrosis Int J Health Allied Sci 4 13 17
M Singh HS Niranjan R Mehrotra D Shrama SC Gupta 2010 Efficacy of hydrocortisone acetate/hyluronidase vs trimcinoloneacetonide/hyaluronidase in the treatment of oral submucous fibrosis Indian J Med Res 131 665
Funding
No funding was received by the authors for this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they do not have any potential conflict of interest.
Ethical Approval
Ethical clearance was given by the institutional ethics committee for this study in accordance with the 1964 Helsinki Declaration.
Informed Consent
A written informed consent was taken by all study participants taking permission for participation and publication of their data.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Verma, P.K., Rana, A.K., Tripathi, S. et al. Evaluation of Clinical Profile and Various Treatment Modalities in Oral Sub Mucous Fibrosis in North India: Our Experience. Indian J Otolaryngol Head Neck Surg 74 (Suppl 3), 6313–6320 (2022). https://doi.org/10.1007/s12070-021-03049-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12070-021-03049-y